News
FDA Inspection Surge Targets Compounded Semaglu...
FDA warning letters from March and April 2026 document specific impurity failures in compounded semaglutide, including N-acetyl semaglutide at 1.8%
FDA Inspection Surge Targets Compounded Semaglu...
FDA warning letters from March and April 2026 document specific impurity failures in compounded semaglutide, including N-acetyl semaglutide at 1.8%